Nirgude, S.; Shahana M. V.; Ravindran, F.; Kumar, S.; Sharma, S.; Mahadeva, R.; Mhatre, A.; Karki, S.S.; Choudhary, B.
A Coumarin–Imidazothiadiazole Derivative, SP11 Abrogates Tumor Growth by Targeting HSP90 and Its Client Proteins. Molecules 2023, 28, 5226.
https://doi.org/10.3390/molecules28135226
AMA Style
Nirgude S, Shahana M. V., Ravindran F, Kumar S, Sharma S, Mahadeva R, Mhatre A, Karki SS, Choudhary B.
A Coumarin–Imidazothiadiazole Derivative, SP11 Abrogates Tumor Growth by Targeting HSP90 and Its Client Proteins. Molecules. 2023; 28(13):5226.
https://doi.org/10.3390/molecules28135226
Chicago/Turabian Style
Nirgude, Snehal, Shahana M. V., Febina Ravindran, Sujeet Kumar, Shivangi Sharma, Raghunandan Mahadeva, Anisha Mhatre, Subhas S. Karki, and Bibha Choudhary.
2023. "A Coumarin–Imidazothiadiazole Derivative, SP11 Abrogates Tumor Growth by Targeting HSP90 and Its Client Proteins" Molecules 28, no. 13: 5226.
https://doi.org/10.3390/molecules28135226
APA Style
Nirgude, S., Shahana M. V., Ravindran, F., Kumar, S., Sharma, S., Mahadeva, R., Mhatre, A., Karki, S. S., & Choudhary, B.
(2023). A Coumarin–Imidazothiadiazole Derivative, SP11 Abrogates Tumor Growth by Targeting HSP90 and Its Client Proteins. Molecules, 28(13), 5226.
https://doi.org/10.3390/molecules28135226